#1 Clinical Trials Search in Europe

Eletriptan

Eletriptan, a second-generation serotonin receptor agonist, has been the subject of several clinical trials exploring its efficacy in treating migraines and other conditions. Originally approved for acute migraine treatment, recent studies have investigated its potential in addressing spinal cord injuries and menstrual migraines. This article summarizes key findings from clinical trials using Eletriptan, highlighting its effectiveness, safety profile, and potential new applications in medical treatment.

Table of Contents

What is Eletriptan?

Eletriptan, also known by its brand name Relpax, is a medication primarily used for treating migraines. It belongs to a class of drugs called serotonin receptor agonists, also known as triptans[1]. Eletriptan has been clinically available for over two decades and is well-characterized in terms of its safety and efficacy profile[1].

Uses of Eletriptan

Eletriptan is primarily used for:

  • Acute treatment of migraine attacks: It is effective in treating migraine headaches with or without aura[2]. Aura refers to sensory disturbances that some people experience before a migraine headache, such as seeing flashing lights or experiencing tingling sensations.
  • Menstrual migraines: Some studies have explored the use of eletriptan in preventing menstrual migraines, which are headaches that occur in relation to a woman’s menstrual cycle[3].

How Eletriptan Works

Eletriptan is a second-generation serotonin receptor agonist. It works by:

  • Binding to specific serotonin receptors: Eletriptan has a high affinity for 5-HT1B, 5-HT1D, and 5-HT1F receptors in the brain[1].
  • Affecting blood vessels: By binding to these receptors, eletriptan can help constrict blood vessels in the brain that may be dilated during a migraine attack.
  • Reducing inflammation: It may also help reduce inflammation in the brain that contributes to migraine pain.

Serotonin is a neurotransmitter (a chemical messenger in the brain) that plays a crucial role in regulating mood, sleep, and pain perception. In the context of migraines, serotonin levels can affect blood vessel dilation and pain signaling[1].

Dosage and Administration

Eletriptan is typically administered as follows:

  • Oral tablets: It is available in 20 mg and 40 mg tablets[4].
  • Dosing: The usual starting dose is 40 mg, taken as soon as migraine symptoms appear[5].
  • Timing: It’s most effective when taken early in the migraine attack, ideally within 2 hours of onset[7].
  • Repeat dosing: If the migraine returns after initial relief, a second dose may be taken after at least 2 hours, but within 24 hours of the first dose[6].

Always follow your doctor’s instructions regarding dosage and timing of eletriptan.

Efficacy of Eletriptan

Clinical trials have shown that eletriptan is effective in treating migraine symptoms:

  • Pain relief: Many patients experience significant pain relief within 2 hours of taking eletriptan[8].
  • Associated symptoms: It can also help alleviate other migraine-related symptoms such as nausea, sensitivity to light (photophobia), and sensitivity to sound (phonophobia)[10].
  • Functional improvement: Patients often report improved ability to function and reduced work productivity loss[5].
  • Consistency: Some studies have shown that eletriptan provides consistent relief across multiple migraine attacks[2].

Side Effects and Safety

Eletriptan is generally well-tolerated, but like all medications, it can cause side effects. Common side effects may include:

  • Dizziness
  • Nausea
  • Fatigue
  • Chest tightness or pain (rarely)

It’s important to discuss any side effects with your healthcare provider. Eletriptan has a good safety profile, but it may not be suitable for everyone, particularly those with certain heart conditions[1].

Eletriptan vs. Other Medications

Studies have compared eletriptan to other migraine medications:

  • vs. Sumatriptan: Some research suggests that eletriptan may be more effective than sumatriptan, another commonly used triptan, in treating acute migraine attacks[10].
  • vs. NSAIDs: Eletriptan has shown efficacy in patients who didn’t respond well to non-steroidal anti-inflammatory drugs (NSAIDs)[6].

Ongoing Research

Research on eletriptan continues, with recent studies exploring:

  • New indications: A recent study is investigating the potential use of eletriptan in treating acute spinal cord injury[1]. This research is based on eletriptan’s effects on serotonin receptors and its potential to promote locomotor recovery in animal models.
  • Optimal dosing strategies: Studies are examining the effects of early intervention with eletriptan on mild versus moderate to severe migraine pain[7].
  • Pharmacokinetics: Research is ongoing to understand how eletriptan is processed in the body across different populations[4].

These ongoing studies may lead to new uses for eletriptan or improved treatment strategies for migraine sufferers in the future.

Aspect Details
Primary Use Acute treatment of migraine headaches, with or without aura
Mechanism of Action Serotonin (5-HT) receptor agonist, targeting 5-HT1B, 5-HT1D, and 5-HT1F receptors
Dosages Studied 20 mg, 40 mg, 80 mg
Efficacy Measures Headache response at 2 hours, pain-free response, functional impairment, associated symptoms
New Potential Applications Acute spinal cord injury (SCI), menstrual migraine prevention
Safety Profile Generally well-tolerated with manageable side effects
Special Populations Studied Korean males (pharmacokinetics), patients unsatisfied with previous treatments
Comparative Studies Compared to placebo, rizatriptan, NSAIDs
Administration Oral tablets, with various dosing regimens depending on the condition

FAQ

  • What is Eletriptan primarily used for? Eletriptan is primarily used for the acute treatment of migraine headaches, with or without aura. It's a second-generation serotonin receptor agonist that has been clinically available for over two decades.
  • What new potential uses for Eletriptan are being studied? Recent clinical trials are exploring Eletriptan's potential in treating acute spinal cord injury (SCI) and menstrual migraines. A Phase 1b/2a trial is investigating its use in early acute SCI, while another study examined its effectiveness in preventing menstrual migraines.
  • How effective is Eletriptan in treating migraines? Clinical trials have shown Eletriptan to be effective in providing migraine relief. One study found that it offers consistent migraine relief across multiple doses. Another trial demonstrated its efficacy in patients who were not satisfied with previous treatments like rizatriptan or NSAIDs.
  • What dosages of Eletriptan have been studied in clinical trials? Clinical trials have studied various dosages of Eletriptan, including 20 mg, 40 mg, and 80 mg. The choice of dosage often depends on the specific condition being treated and the individual patient's response.
  • Are there any notable side effects of Eletriptan? While Eletriptan is generally well-tolerated, clinical trials monitor for treatment-emergent adverse events (AEs) and serious adverse events (SAEs). The specific side effects can vary, but the drug is noted to have a manageable safety profile. As with any medication, it's important to discuss potential side effects with a healthcare provider.

Ongoing Clinical Trials on Eletriptan

  • Study on the Safety and Effectiveness of TZ-161 for Adults with Early Acute Spinal Cord Injury

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Portugal Spain

Glossary

  • Eletriptan hydrobromide (HBr): A second-generation serotonin receptor agonist used for treating acute migraine headaches. It works by binding to specific serotonin receptors in the brain.
  • Serotonin (5-HT) receptor: A type of receptor in the brain that responds to the neurotransmitter serotonin. Eletriptan targets specific subtypes of these receptors (5-HT1B, 5-HT1D, and 5-HT1F) to help relieve migraine symptoms.
  • Migraine aura: Sensory disturbances that some people experience before or during a migraine headache. These can include visual changes, tingling sensations, or difficulty speaking.
  • Spinal Cord Injury (SCI): Damage to the spinal cord that can result in loss of function, sensation, or mobility below the level of injury. Recent studies are exploring Eletriptan's potential in treating acute SCI.
  • Menstrual migraine: Migraine headaches that occur in association with a woman's menstrual cycle, typically starting before or during menstruation.
  • Pharmacokinetics (PK): The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion. PK studies help determine appropriate dosing and potential differences among populations.
  • Area Under the Curve (AUC): A measure used in pharmacokinetics to represent the total exposure to a drug over time. It's calculated from a graph of drug concentration in the blood versus time.
  • Maximum Observed Plasma Concentration (Cmax): The highest concentration of a drug observed in the blood plasma after administration. It's an important measure in understanding a drug's effects and potential side effects.
  • Headache index: A score used to measure headache severity, typically calculated by averaging pain intensity scores recorded multiple times daily.
  • Standard of Care (SOC): The treatment approach that is accepted by medical experts as the most appropriate and widely used for a specific condition.

References

  1. https://clinicaltrials.gov/study/NCT06677229
  2. https://clinicaltrials.gov/study/NCT01859481
  3. https://clinicaltrials.gov/study/NCT00259649
  4. https://clinicaltrials.gov/study/NCT01139515
  5. https://clinicaltrials.gov/study/NCT00632385
  6. https://clinicaltrials.gov/study/NCT00634985
  7. https://clinicaltrials.gov/study/NCT00174395
  8. https://clinicaltrials.gov/study/NCT01978496
  9. https://clinicaltrials.gov/study/NCT01989936
  10. https://clinicaltrials.gov/study/NCT01986088